Efficacy and Safety Study to Compare Formoterol Fumerate in the Pressair DPI to the Foradil Aerolizer in Patient With Mild to Moderate Asthma
Completed · Phase 2 · Has a placebo group
Conditions studied: Asthma
In brief
The purpose of this Phase II study is to evaluate efficacy and safety of inhaled formoterol fumarate in the Pressair DPI compared to the Foradil Aerolizer in patients with mild to moderate asthma. This study will include a screening visit followed by a 4 month treatment period.
Key facts
- Study ID
- NCT01641081
- Run by
- AstraZeneca
- People needed
- 174
- Starts
- 2012-06-01
- Expected to finish
- 2013-02-01
- Last updated by the study team
- 2017-02-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Forest Investigative Site 909 — Phoenix, Arizona, United States
- Forest Investigative Site 2066 — Encinitas, California, United States
- Forest Investigative Site 1624 — Los Angeles, California, United States
- Forest Investigative Site 1995 — Mission Viejo, California, United States
- Forest Investigative Site 1347 — San Jose, California, United States
- Forest Investigative Site 1996 — Centennial, Colorado, United States
- Forest Investigative Site 1137 — Colorado Springs, Colorado, United States
- Forest Investigative Site 1998 — Denver, Colorado, United States
- Forest Investigative Site 2047 — Tampa, Florida, United States
- Forest Investigative Site 1536 — Louisville, Kentucky, United States
- Forest Investigative Site 1333 — Baltimore, Maryland, United States
- Forest Investigative Site 1431 — North Dartmouth, Massachusetts, United States
- Forest Investigative Site 2041 — Minneapolis, Minnesota, United States
- Forest Investigative Site 1599 — St Louis, Missouri, United States
- Forest Investigative Site 1609 — Bellevue, Nebraska, United States
- Forest Investigative Site 1999 — Skillman, New Jersey, United States
- Forest Investigative Site 1153 — Raleigh, North Carolina, United States
- Forest Investigative Site 1134 — Canton, Ohio, United States
- Forest Investigative Site 1806 — Cincinnati, Ohio, United States
- Forest Investigative Site 1176 — Oklahoma City, Oklahoma, United States
- Forest Investigative Site 2043 — Medford, Oregon, United States
- Forest Investigative Site 1580 — Portland, Oregon, United States
- Forest Investigative Site 2025 — Charleston, South Carolina, United States
- Forest Investigative Site 1155 — Dallas, Texas, United States
- Forest Investigative Site 1332 — El Paso, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.